Clover Health CGO Prabhdeep Singh to depart March 31, 2023; consulting role set

CLOVER HEALTH INVESTMENTS, CORP. /DE

Singh steps down as Chief Growth Officer effective March 31, 2023.
Will provide consulting services for three months at $15,000/month.
Company pays three months of COBRA premiums if elected.
No successor announced; CEO Andrew Toy praised Singh's contributions.
Separation and Consulting Agreement to be executed with standard release.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Prabhdeep Singh

Chief Growth Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2023-03-31
Filed: January 20, 2023, 6:59 PM ET

On January 20, 2023, Prabhdeep Singh notified Clover Health Investments, Corp. (the "Company") that he will be stepping down from his position as Chief Growth Officer of the Company, effective March 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Prabhdeep Singh departed as Chief Growth Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: stepping down
Role: Chief Growth Officer

Exact text from the filing

On January 20, 2023, Prabhdeep Singh notified Clover Health Investments, Corp. (the "Company") that he will be stepping down from his position as Chief Growth Officer of the Company, effective March 31, 2023.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-23-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.